ARS Pharmaceuticals, Inc. (SPRY) Executive Compensation
ARS Pharmaceuticals, Inc. (SPRY) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SPRY
CIK: 1671858
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerBrian Valenzuela
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-05 | 2026-10-01 | 4 Filing | 0002135296-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001950047-26-009969 | View SEC Doc Filr Page |
| 144 | 2026-09-30 | — | 144 Filing | 0001950047-26-009892 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001950047-26-009340 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001950047-26-009329 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001950047-26-009120 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001950047-26-009066 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-01 | 4 Filing | 0002149973-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001950047-26-009041 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001950047-26-008961 | View SEC Doc Filr Page |
| 144 | 2026-08-31 | — | 144 Filing | 0001950047-26-008852 | View SEC Doc Filr Page |
| 144 | 2026-08-20 | — | 144 Filing | 0001950047-26-008488 | View SEC Doc Filr Page |
| 144 | 2026-08-20 | — | 144 Filing | 0001950047-26-008459 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001950047-26-008389 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001950047-26-008376 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001950047-26-008362 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001950047-26-008357 | View SEC Doc Filr Page |
| 3 | 2026-08-17 | 2026-08-17 | 3 Filing | 0002149973-26-000002 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349140 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349127 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002251 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-15 | 8-K | 0001193125-26-307773 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-083589 | View SEC Doc Filr Page |
| 8-K | 2026-07-07 | 2026-07-06 | 8-K | 0001193125-26-297554 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | 4 Filing | 0002135296-26-000007 | View SEC Doc Filr Page |